The FDA announced a crackdown on sending American DNA to labs in China and other adversaries. Previously, research on genetic manipulation of U.S. citizens’ cells was outsourced abroad, sometimes without participant knowledge. New export controls now limit this flow, closing loopholes that allowed biological materials to be exported, even by firms tied to the Chinese Communist Party. The policy aims to protect Americans’ genetic data amid rising cell and gene therapy trials.
Trump Admin Closes Biden-Era Loophole That Let China Scoop Up Americans’ DNA
